We have previously shown that pentoxifylline (PTX) protects from vascular complications associated with insulin resistance (IR). Here, we investigated the protective effect of PTX against cardiac ischemia and dysfunction following experimental angina in IR. IR, along with its accompanying cardiac dysfunction, was induced in rats by a high-fructose (10% in drinking water) high-fat diet for 12 weeks. PTX was administered daily (30 mg？kg？1) during the last 4 weeks of the study. Experimental angina was induced by isoproterenol (10 μg？kg？1) administered by intravenous injection. Both before (baseline) and after the experimental angina, cardiac contractility was assessed by continuous recording in anesthetized rats via a microtip catheter inserted in the left ventricle, and cardiac conductivity was determined by a surface electrocardiograph. Serum glucose, insulin, tumor necrosis factor-α (TNFα), and adiponectin levels and lipid profile were also determined. Feeding the rats a high-fructose high-fat diet produced IR, as evidenced by significant hyperinsulinemia and hyperglycemia, and PTX administration did not affect this IR. When subjected to experimental angina, IR hearts were less resistant to the ischemia following induction of angina (reflected by the large ST height depression) compared with controls, and PTX completely prevented the excessive ST height depression in IR animals. In addition, left ventricular pressure development was largely attenuated during and after induction of angina in IR animals compared with controls. PTX administration prevented the excessive attenuation in ventricular pressure development in IR animals. IR was associated with elevated levels of the inflammatory cytokine TNFα, whereas PTX treatment elevated the serum level of the anti-inflammatory cytokine adiponectin. PTX alleviates cardiac ischemia and dysfunction following experimental angina in IR directly through inhibition of the low-grade inflammation that accompanies IR.
References
[1]
Raskin P (2010) Risk factors for the development of diabetic complications. Journal of Diabetes and its Complications 8: 195–200. Doi: 10.1016/1056-8727(94)90043-4.
[2]
DeFronzo RA, Del Prato S (2009) Insulin resistance and diabetes mellitus. Journal of Diabetes and its Complications 10: 243–245. Doi: 10.1016/1056-8727(96)00046-3.
[3]
Busija DW, Miller AW, Katakam P, Erdos B (2006) Adverse effects of reactive oxygen species on vascular reactivity in insulin resistance. Antioxid Redox Signal 8: 1131–1140. doi: 10.1089/ars.2006.8.1131
[4]
Marks JB, Raskin P (2003) Cardiovascular risk in diabetes: A brief review. Journal of Diabetes and its Complications 14: 108–115, Doi: 10.1016/S1056-8727(00)00065-9.
[5]
Dhurandhar RW, Watt DL, Silver MD, Trimble AS, Adelman AG (1972) Prinzmetal's variant form of angina with arteriographic evidence of coronary arterial spasm. The American Journal of Cardiology 30: 902–905. doi: 10.1016/0002-9149(72)90018-5
[6]
Yasue H, Omote S, Takizawa A, Nagao M (1983) Coronary arterial spasm in ischemic heart disease and its pathogenesis. A review. Circulation Research 52: I.
[7]
Soliman EZ, Prineas RJ, Case LD, Russell G, Rosamond W, et al. (2011) Electrocardiographic and clinical predictors separating atherosclerotic sudden cardiac death from incident coronary heart disease. Heart 97: 1597–1601. doi: 10.1136/hrt.2010.215871
[8]
Chen H (2006) Cellular inflammatory responses: novel insights for obesity and insulin resistance. Pharmacol Res 53: 469–477. doi: 10.1016/j.phrs.2006.03.003
[9]
Shaw SM, Shah MKH, Williams SG, Fildes JE (2009) Immunological mechanisms of pentoxifylline in chronic heart failure. Eur J Heart Fail 11: 113–118. doi: 10.1093/eurjhf/hfn040
[10]
Seiffge D, Kremer E (1984) Antithrombotic effects of pentoxifylline on laser-induced thrombi in rat mesenteric arteries. IRCS Medical Science 12: 91–92.
[11]
Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short RA, et al. (2006) A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 290: F625–F631. doi: 10.1152/ajprenal.00140.2005
[12]
Field KJ, White WJ, Lang CM (1993) Anaesthetic effects of chloral hydrate, pentobarbitone and urethane in adult male rats. Laboratory Animals 27: 258–269. doi: 10.1258/002367793780745471
[13]
Yamamoto S, Matsui K, Sasabe M, Kitano M, Ohashi N (2000) Effect of SMP-300, a new Na+/H+ exchange inhibitor, on myocardial ischemia and experimental angina models in rats. Jpn J Pharmacol 84: 196–205. doi: 10.1254/jjp.84.196
[14]
Radovits T, Bomicke T, Kokeny G, Arif R, Loganathan S, et al. (2009) G (2009) The phosphodiesterase-5 inhibitor vardenafil improves cardiovascular dysfunction in experimental diabetes mellitus. Br J Pharmacol 156: 909–919. doi: 10.1111/j.1476-5381.2008.00098.x
[15]
Mori T, Ishigai Y, Fukuzawa A, Chiba K, Shibano T (1995) Pharmacological profile of semotiadil fumarate, a novel calcium antagonist, in rat experimental angina model. Br J Pharmacol 116: 1668–1672. doi: 10.1111/j.1476-5381.1995.tb16389.x
[16]
Williams IL, Vazir A, Zaman AG (2003) Review: The management of stable angina in diabetes. The British Journal of Diabetes & Vascular Disease 3: 18–25. doi: 10.1177/14746514030030010301
[17]
Zhang M, LXY, Zhang HY, Wang CM, Chen L (2008) The protective effect of pentoxifylline on myocardium injury induced by ischemia-reperfusion and Ca2+ paradox. Chin Pharmacol Bull 24: 937–941.
[18]
Maslov LN, Lasukova OV, Krylatov AV, Hanus LO, Pertwee R, et al. (2006) Role of cannabinoid receptors in the regulation of cardiac contractility during ischemia/reperfusion. Bull Exp Biol Med 142: 557–561. doi: 10.1007/s10517-006-0417-4
[19]
Osadchii O, Norton G, Woodiwiss A (2005) Inotropic responses to phosphodiesterase inhibitors in cardiac hypertrophy in rats. Eur J Pharmacol 514: 201–208. doi: 10.1016/j.ejphar.2005.03.022
[20]
Robinson DA, Wang P, Chaudry IH (1996) Pentoxifylline restores the depressed cardiac performance after trauma- hemorrhage and resuscitation. J SURG RES 66: 51–56. doi: 10.1006/jsre.1996.0371
[21]
Schìfer S, Huber J, Wihler C, Rtten H, Busch AE, et al. (2006) Impaired left ventricular relaxation in type 2 diabetic rats is related to myocardial accumulation of N-(carboxymethyl)lysine. Eur J Heart Fail 8: 2–6. doi: 10.1016/j.ejheart.2006.08.005
[22]
Loganathan R, Bilgen M, Al-Hafez B, Alenezy MD, Smirnova IV (2006) Cardiac dysfunction in the diabetic rat: Quantitative evaluation using high resolution magnetic resonance imaging. Cardiovasc Diabetol 4; 5: 7.
[23]
Radovits T, Korkmaz S, Loganathan S, Barnucz E, B micke T, et al. (2009) Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol - Heart Circ Physiol 297: H125–H133. doi: 10.1152/ajpheart.00165.2009
[24]
Zhang M, L XY, Zhang HY, Wang CM, Chen L (2008) The protective effect of pentoxifylline on myocardium injury induced by ischemia-reperfusion and Ca2+ paradox. Chin Pharmacol Bull 24: 937–941.
[25]
Pickup JC (2004) Inflammation and Activated Innate Immunity in the Pathogenesis of Type 2 Diabetes. Diabetes Care 27: 813–823. doi: 10.2337/diacare.27.3.813
Mahmoud MF, Hassan NA, El Bassossy HM, Fahmy A (2013) Quercetin Protects against Diabetes-Induced Exaggerated Vasoconstriction in Rats: Effect on Low Grade Inflammation. PLoS ONE 8(5): e63784. doi: 10.1371/journal.pone.0063784
[28]
Yamauchi T, Kamon J, Minokoshi Y, Ito Y, Waki H, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8: 1288–1295. doi: 10.1038/nm788
[29]
Miller RA, Chu Q, Le Lay J, Scherer PE, Ahima RS, Kaestner KH, Foretz M, Viollet B, Birnbaum MJ (2011) Adiponectin suppresses gluconeogenic gene expression in mouse hepatocytes independent of LKB1-AMPK signaling. J Clin Invest 121: 2518–2528. doi: 10.1172/jci45942
